Márk Harmat

439 total citations
9 papers, 248 citations indexed

About

Márk Harmat is a scholar working on Neurology, Cellular and Molecular Neuroscience and Clinical Psychology. According to data from OpenAlex, Márk Harmat has authored 9 papers receiving a total of 248 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Neurology, 2 papers in Cellular and Molecular Neuroscience and 2 papers in Clinical Psychology. Recurrent topics in Márk Harmat's work include Parkinson's Disease Mechanisms and Treatments (9 papers), Neurological disorders and treatments (8 papers) and Stuttering Research and Treatment (2 papers). Márk Harmat is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (9 papers), Neurological disorders and treatments (8 papers) and Stuttering Research and Treatment (2 papers). Márk Harmat collaborates with scholars based in Hungary and Spain. Márk Harmat's co-authors include Norbert Kovács, József Janszky, Márton Kovács, Kázmér Karádi, Attila Makkos, Zsuzsanna Aschermann, Sámuel Komoly, Krisztina Horváth, István Balás and Gabriella Deli and has published in prestigious journals such as Scientific Reports, Movement Disorders and Parkinsonism & Related Disorders.

In The Last Decade

Márk Harmat

9 papers receiving 244 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Márk Harmat Hungary	7	207	47	36	35	32	9	248
Fernando Cubillos United States	7	205 1.0×	64 1.4×	27 0.8×	49 1.4×	38 1.2×	10	267
Angelika Nebe Germany	4	336 1.6×	28 0.6×	42 1.2×	28 0.8×	41 1.3×	5	367
Kateřina Zárubová Czechia	8	145 0.7×	56 1.2×	36 1.0×	35 1.0×	44 1.4×	9	222
A. Castro Spain	8	194 0.9×	28 0.6×	24 0.7×	16 0.5×	54 1.7×	13	236
Seyed Amir Hassan Habibi Iran	10	131 0.6×	57 1.2×	16 0.4×	46 1.3×	14 0.4×	34	252
Joseph L. Flanigan United States	10	215 1.0×	41 0.9×	60 1.7×	15 0.4×	58 1.8×	17	278
Mahmood Attar Italy	5	233 1.1×	47 1.0×	36 1.0×	59 1.7×	43 1.3×	6	298
Priya Jagota Thailand	10	228 1.1×	34 0.7×	45 1.3×	12 0.3×	40 1.3×	27	277
Íñigo Garamendi Spain	6	119 0.6×	65 1.4×	52 1.4×	25 0.7×	28 0.9×	7	192
Mirosława Derejko Poland	9	315 1.5×	41 0.9×	45 1.3×	24 0.7×	37 1.2×	20	378

Countries citing papers authored by Márk Harmat

Since Specialization

Citations

This map shows the geographic impact of Márk Harmat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Márk Harmat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Márk Harmat more than expected).

Fields of papers citing papers by Márk Harmat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Márk Harmat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Márk Harmat. The network helps show where Márk Harmat may publish in the future.

Co-authorship network of co-authors of Márk Harmat

This figure shows the co-authorship network connecting the top 25 collaborators of Márk Harmat. A scholar is included among the top collaborators of Márk Harmat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Márk Harmat. Márk Harmat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Balás, István, et al.. (2022). Antiparkinsonian Drug Reduction After Directional Versus Omnidirectional Bilateral Subthalamic Deep Brain Stimulation. Neuromodulation Technology at the Neural Interface. 26(2). 374–381. 13 indexed citations

Harmat, Márk, et al.. (2020). The Impact of Trimetazidine on Disease Severity and Quality of Life in Parkinson’s Disease. Scientific Reports. 10(1). 10050–10050. 4 indexed citations

Kovács, Márton, et al.. (2019). Trimetazidine and parkinsonism: A prospective study. Parkinsonism & Related Disorders. 62. 117–121. 12 indexed citations

Forjaz, María João, Pablo Martínez‐Martín, Carmen Rodríguez‐Blázquez, et al.. (2019). Which Scale Best Detects Treatment Response of Tremor in Parkinsonism?. Journal of Parkinson s Disease. 10(1). 275–282. 4 indexed citations

Kovács, Márton, Attila Makkos, Márk Harmat, et al.. (2018). Comparing Sensitivity and Specificity of Addenbrooke’s Cognitive Examination-I, III and Mini-Addenbrooke’s Cognitive Examination in Parkinson’s Disease. Behavioural Neurology. 2018. 1–9. 10 indexed citations

Makkos, Attila, Márton Kovács, Zsuzsanna Aschermann, et al.. (2018). Are the MDS‐UPDRS–Based Composite Scores Clinically Applicable?. Movement Disorders. 33(5). 835–839. 24 indexed citations

Deli, Gabriella, Zsuzsanna Aschermann, József Janszky, et al.. (2017). How Efficient Is Subthalamic Deep Brain Stimulation in Reducing Dyskinesia in Parkinson's Disease?. European Neurology. 77(5-6). 281–287. 8 indexed citations

Horváth, Krisztina, Zsuzsanna Aschermann, Márton Kovács, et al.. (2017). Changes in Quality of Life in Parkinson's Disease: How Large Must They Be to Be Relevant?. Neuroepidemiology. 48(1-2). 1–8. 101 indexed citations

Horváth, Krisztina, Zsuzsanna Aschermann, Márton Kovács, et al.. (2017). Minimal clinically important differences for the experiences of daily living parts of movement disorder society–sponsored unified Parkinson's disease rating scale. Movement Disorders. 32(5). 789–793. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact